Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01663857
Title A Study of LY2228820 for Recurrent Ovarian Cancer
Recruitment Completed
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications
Therapies
Age Groups: adult
Covered Countries USA | DEU | BEL | AUS

Facility Status City State Zip Country Details
St Josephs Hospital and Medical Center Phoenix Arizona 85013 United States Details
Arizona Oncology Associates, P.C. Tucson Arizona 85710 United States Details
Sarasota Memorial Hospital Sarasota Florida 34239 United States Details
H Lee Moffitt Cancer Center Tampa Florida 33612 United States Details
Franklin Square Hospital Center Baltimore Maryland 21237 United States Details
Barnes Jewish Hospital Saint Louis Missouri 63110 United States Details
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08901 United States Details
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 United States Details
Thomas Jefferson University Philadelphia Pennsylvania 19107 United States Details
SMO Sarah Cannon Research Inst. Nashville Tennessee 37203 United States Details
Texas Oncology-Baylor Charles A. Sammons Cancer Center Austin Texas 78731 United States Details
Texas Oncology-Baylor Charles A. Sammons Cancer Center Bedford Texas 76022 United States Details
Texas Oncology-Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 United States Details
Texas Oncology-Baylor Charles A. Sammons Cancer Center Fort Worth Texas 76104 United States Details
Cancer Care Centers of South Texas San Antonio Texas 78229 United States Details
Texas Oncology - The Woodlands The Woodlands Texas 77380 United States Details
US Oncology The Woodlands Texas 77380 United States Details
Tyler Cancer Center Tyler Texas 75702 United States Details
Northwest Cancer Specialists PC Vancouver Washington 98684 United States Details
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Adelaide 5000 Australia Details
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Greenslopes 4120 Australia Details
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nedlands 6009 Australia Details
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Parkville 3053 Australia Details
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leuven 3000 Belgium Details
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin 10117 Germany Details
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Essen 45122 Germany Details
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Essen 45136 Germany Details
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Greifswald 17489 Germany Details
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mainz 55131 Germany Details
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. München 81675 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field